Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FDL06
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,716
Award facts
- Contract value 100% obligated
- $34,715.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $34,715.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 68 milligram Nexplanon implants. The award was issued on August 12, 2025, with an ultimate completion date of September 3, 2025. This delivery order does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. The contract represents a specific procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
Nexplanon implants are subdermal contraceptive devices that provide long-acting reversible birth control and are commonly utilized within military and federal healthcare systems. DMS Pharmaceutical Group's core business involves distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare facilities. The company has maintained registration in SAM.gov since 2001 and has established itself as a crucial supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure recurring contract awards from the DLA. This delivery order exemplifies the company's ongoing role in providing essential pharmaceutical products to support the medical supply needs of Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FDL06?
SPE2DB25FDL06 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FDL06 worth?
The government has obligated $34,716 on SPE2DB25FDL06.
Is contract SPE2DB25FDL06 an order under another contract?
Yes. SPE2DB25FDL06 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL06 competed?
The extent of competition for SPE2DB25FDL06 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award